Luxendo grabs Series A funds
Germany-based Luxendo, a spin-off from the European Molecular Biology Laboratory, has raised an additional 8 million euros in Series A funding. The investors included Life Science Partners and EMBL Ventures.
12 January 2017•5 mins read
